Setting new benchmarks in medical research
Macquarie co-locates the best researchers with our hospital and health precinct, creating world-leading new expertise with real-world benefits.
Areas of specialisation
- Basic pharmacology
- Cancer cell biology
- Cancer therapy
- Cardiovascular and respiratory medicine
- Cellular nervous system
- Central nervous system
- Clinical sciences
- Liquid biopsies
- Medical biotechnology
- Medical genetics
- Medical physiology
- Nanobiotechnology
- Neurogenetics
- Neurology and neuromuscular diseases, including MND and dementias
- Neurosciences
- Ophthalmology
- Pharmaceutical delivery technologies
- Predictive and prognostic markers
- Vision science.
Learn more about our research strengths.
Research collectives
Research highlights
Our research directly affects patient outcomes across a range of medical conditions and interventions.
Treating MND – Macquarie Neurology and Macquarie’s Motor Neuron Disease (MND) Service combines academic and clinical services with Australia's largest concentration of MND researchers, providing patients with bespoke care. This supports a translational research platform that has made important discoveries of genetic origins of familial MND, which has enabled MND pre-implantation in vitro fertilisation (IVF) services to ensure babies are free of MND in Australia. Our genetic discoveries have also been incorporated into standard practice diagnostic genetic testing of MND patients that are used worldwide.
A simple blood test could soon diagnose cancer – Professor Helen Rizos leads team using liquid biopsies to test patients' responses to cancer treatments and to predict survival outcomes. Read more about this research.
Real-world innovation – Macquarie University launched Celosia Therapeutics to develop effective treatments for neurodegenerative diseases. Read more about this research.
Research news
Read more about the breakthroughs happening in the areas of research relating to biomedical and clinical sciences.